MRD Monitoring Market Assessment and Strategy
Clinical Diagnostics
60
12
30
Biomarker and Diagnostics Strategy
Go-to-Market Strategy
Market Landscaping and Sizing
Objective
A diagnostics player wanted to determine with indications / use cases to target and develop a product road map
Our Approach
Primary Research
- Conducted 30 interviews with clinicians and biopharma stakeholders to assess the opportunities for MRD in research and clinical diagnostics
- Assessed the pain-points and unmet needs associated with existing offerings, and the desired methods, performance specifications, configurations, and workflows for an ideal offering
- Specified and prioritized the indications and applications where MRD and monitoring is most impactful, and the product requirements needed for each application
Secondary Research
- Assessed the competitive landscape and clinical workflows in specific indications to understand how the company fits in; reviewed clinical trial activity to identify competitive gaps where new players can compete
- Assessed epidemiology and clinical workflows to understand the relatives sizes of the different MRD / monitoring applications by cancer type
Outcome
DeciBio presented to the client a deliverable discussing discrete use cases of the highest interest to the client team, and deep dives of each. Additional content include:
- U.S. ctDNA MRD and monitoring landscape size
- Top use case prioritized by client differentiation and attractiveness
- Primary feedback highlights regarding potential utility by indication
Related Client Results
Longitudinal Monitoring of Cancer Early Detection Market
Competitive Analysis
Cell and Gene Therapy Services Landscape Assessment
No items found.
NIPT Market Landscape and Strategy
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation
Go-to-Market Strategy
